UiPath, Inc.
PATHNew York Stock ExchangeFull coverage
Price
Loading your watchlists
Income statement
For a spreadsheet set to a decimal comma. Applies to Copy table and Download CSV.
USD millions · shares in millions · per-share in USD
| Line | Trend | FY 2026Ended Jan 31, | FY 2025Ended Jan 31, | FY 2024Ended Jan 31, | FY 2023Ended Jan 31, | FY 2022Ended Jan 31, | FY 2021Ended Jan 31, | FY 2020Ended Jan 31, |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Cost of revenue | ||||||||
| Gross profit | ||||||||
| Research and development | ||||||||
| Selling, general and administrative | ||||||||
| Selling and marketing | ||||||||
| General and administrative | ||||||||
| Restructuring charges | ||||||||
| Goodwill impairment | ||||||||
| Operating expenses | ||||||||
| Operating income | ||||||||
| Interest income | ||||||||
| Non-operating income (expense), net | ||||||||
| Other non-operating income (expense) | ||||||||
| Income before taxes | ||||||||
| Income tax | ||||||||
| Net income | ||||||||
| Basic EPS | ||||||||
| Diluted EPS | ||||||||
| Weighted average shares (basic) | ||||||||
| Weighted average shares (diluted) | ||||||||
| Other comprehensive income, including non-controlling interests | ||||||||
| Unrealized gains (losses) on available-for-sale securities | ||||||||
| Other comprehensive income | ||||||||
| Comprehensive income | ||||||||
| Lease cost | ||||||||
| Operating lease cost | ||||||||
Use the arrow keys to move between values, and Enter to see where a value comes from.
Growth
| Line | Q2 2027vs a year earlier | 1 year | 3 years | 5 years |
|---|---|---|---|---|
| Revenue | ||||
| Gross profit | ||||
| Diluted EPS | ||||
| Free cash flow | ||||
| Diluted share count |
Margins
An item moved a margin in this period
| Margin | TTM Q3 2022Ended Oct 31, | TTM Q4 2022Ended Jan 31, | TTM Q1 2023Ended Apr 30, | TTM Q2 2023Ended Jul 31, | TTM Q3 2023Ended Oct 31, | TTM Q4 2023Ended Jan 31, | TTM Q1 2024Ended Apr 30, | TTM Q2 2024Ended Jul 31, | TTM Q3 2024Ended Oct 31, | TTM Q4 2024Ended Jan 31, | TTM Q1 2025Ended Apr 30, | TTM Q2 2025Ended Jul 31, | TTM Q3 2025Ended Oct 31, | TTM Q4 2025Ended Jan 31, | TTM Q1 2026Ended Apr 30, | TTM Q2 2026Ended Jul 31, | TTM Q3 2026Ended Oct 31, | TTM Q4 2026Ended Jan 31, | TTM Q1 2027Ended Apr 30, | TTM Q2 2027Ended Jul 31, |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | ||||||||||||||||||||
| Operating margin | ||||||||||||||||||||
| Net margin | ||||||||||||||||||||
| EBITDA margin | ||||||||||||||||||||
| FCF margin |